🇮🇱 Norepinephrine Bitartrate In 5% Dextrose in Israel

Norepinephrine Bitartrate In 5% Dextrose (NOREPINEPHRINE) regulatory status in Israel.

Marketing authorisations

MOH

  • Status: likely_approved

MOH

  • Status: likely_approved

MOH

  • Status: likely_approved

MOH

  • Status: likely_approved

MOH

  • Status: likely_approved

MOH

  • Status: likely_approved

Norepinephrine Bitartrate In 5% Dextrose in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in Israel

Frequently asked questions

Is Norepinephrine Bitartrate In 5% Dextrose approved in Israel?

Yes. MOH has authorised it; MOH has authorised it; MOH has authorised it.

Who is the marketing authorisation holder for Norepinephrine Bitartrate In 5% Dextrose in Israel?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.